Uncertainty around health care reform and FDA regulations may be hindering global financing for U.S companies in fields such as biotechnology, pharmaceuticals and biomedical technologies.
Corning CEO Wendel Weeks has bolstered Corning’s finances, product diversity and research. In a recent interview, Weeks discussed how lessons from the past augur well for Corning’s future.
